# Case Report: Long-term follow-up of a schoolboy with Gitelman syndrome and epilepsy—causation or coincidence?

**Authors:** Jiao Xue, Ying Zhang, Hongshan Zhao, Fei Li, Chengqing Yang, Zhi Yi, Kaixuan Liu, Zhenfeng Song

PMC · DOI: 10.3389/fped.2026.1772948 · 2026-03-05

## TL;DR

A 12-year-old boy with Gitelman syndrome and epilepsy is reported, raising questions about whether the epilepsy is caused by the syndrome or is a coincidence.

## Contribution

This case report highlights a rare co-occurrence of Gitelman syndrome and epilepsy, suggesting a potential but unproven causal link.

## Key findings

- The patient's seizures were controlled with levetiracetam.
- The patient's serum magnesium levels were initially normal but later decreased.
- The etiology of epilepsy in this case remains unclear.

## Abstract

Gitelman syndrome (GS) presents with a broad range of clinical manifestations. Although uncommon, seizures secondary to severe metabolic alkalosis or hypomagnesemia have been documented. A concurrent diagnosis of epilepsy in patients with GS is even rarer.

We report the case of a 12-year-old boy whose chief complaint was recurrent convulsions. Initial laboratory evaluation revealed normal serum magnesium levels, which subsequently decreased during follow-up. Persistent hypokalemia, hyperaldosteronism, and hypomagnesemia in subsequent disease course, as well as mutations of the SLC12A3 gene, confirmed the diagnosis of GS. Based on long-term monitoring of seizure episodes, electroencephalogram findings, and the electrolyte levels during an epileptic seizure, a diagnosis of epilepsy was established. His seizures were well controlled with levetiracetam.

We report a case of GS presenting with convulsions as the chief complaint. The etiology of epilepsy in this case remains unclear and may represent either a causal association or a coincidental comorbidity with GS. The mechanism of the atypical dynamics of serum magnesium levels in this patient—normal levels initially followed by a subsequent decrease—warrants further investigation.

## Linked entities

- **Genes:** SLC12A3 (solute carrier family 12 member 3) [NCBI Gene 6559]
- **Diseases:** Gitelman syndrome (MONDO:0009904), epilepsy (MONDO:0005027)

## Full-text entities

- **Genes:** SLC12A3 (solute carrier family 12 member 3) [NCBI Gene 6559] {aka NCC, NCCT, TSC}
- **Diseases:** metabolic alkalosis (MESH:D000471), hypokalemia (MESH:D007008), hyperaldosteronism (MESH:D006929), epilepsy (MESH:D004827), hypomagnesemia (OMIM:613882), convulsions (MESH:D012640), GS (MESH:D053579)
- **Chemicals:** levetiracetam (MESH:D000077287), magnesium (MESH:D008274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12999940